Trade Summary

3 days ago, Fordyce Marshall, serving as PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 18,500 shares at $37.93 per share, for a total transaction value of $701,769.25. Following this transaction, Fordyce Marshall now holds 198,244 shares of VERA.

This sale represents a 8.54% decrease in Fordyce Marshall's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 4:55 PM ET, 1 day after the trade was made.

Vera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.